Orphan Drugs for Rare Diseases Summit

Orphan Drugs for Rare Diseases Summit is organized by Vonlanthen Group of Companies and will be held during Mar 22 - 23, 2018 at Berlin, Germany.

The target audience for this medical event is Chief Executives, Directors, Vice Presidents, Heads and Leaders specializing in Personalized Medicine, Drug Discovery & Development, Experimental Medicine, Translational Medicine, Stratified Medicine, Innovative Medicine, Cell / Molecular Biology, Regenerative Medicine, Diagnostic Development, Molecular Diagnostics, Targeted Therapy, Cell / Gene Therapy, Genetic Diseases, Rare & ultra-rare Diseases, Endocrinology, Metabolic & Gastrointestinal (GI) disorders, Cancer / Oncology.

Course Objectives are:
• Cutting-edge science and tech to enhance rare diseases research, diagnosis and therapeutics.
• Novel drug modalities, assays & models, therapeutic strategies
• Employee wellbeing & health in relation to office design
• Emerging approaches for effective, fast, affordable and successful orphan drugs development
• Insights into regulatory, pricing, reimbursement, commercialization, market access for rare disorders drugs

Additional details will be posted as soon as they are available.